Spectrascience Timeline 2012 through Today All my

New Post Public Reply Private Reply Replies (0) Message Board
joey68
Spectrascience Timeline 2012 through Today

All my opinion..

Looking at a brief overview of the company, we can see that SCIE has made a lot of progress in a relatively short period of time:

Note:
Also notice, when looking at the following PRs in order, its obvious to see how transparent SCIE is with their investors.

2012

May 2012 - WavSTAT Optical Biopsy System Highlighted in Presentations at Digestive Disease Week Conference

July 2012 - SpectraScience to Present at the OneMed Forum /
SpectraScience Reports Estimated Second Quarter Revenue of $310,000

September 2012 - SpectraScience Completes Initial WavSTAT4 Installation and Training With PENTAX Europe

October 2012 - SpectraScience WavSTAT Optical Biopsy System to Be Featured at United European Gastroenterology Week Conference in Amsterdam

November 2012 - SpectraScience to Hold Business Update Conference Call on November 20, 2012

December 2012 - SpectraScience to Present at LD Micro Growth Conference on December 6, 2012

2013

January 2013 - SpectraScience and PENTAX Showcase WaveSTAT4 Optical Biopsy System at Arab Health 2013

April 2013 - SpectraScience Rescheduling Workshops Due to High Demand

Have you read this PR? Its crazy! So much demand, SCIE had to reschedule!

June 2013 - SpectraScience, Inc. Announces Positive Results From Study by Dr. Helmut Neumann / SpectraScience, Inc. Announces Minimum Purchase Agreement With PENTAX Medical / SpectraScience Announces Q2 2013 Revenue $120,000

(Many more PR's would fit here but I'm not taking the time to list them all. Do your DD and youll find them)

2014

April 2014 - SpectraScience Announces SFDA Approval in Saudi Arabia for WavSTAT4

(Many more PR's would fit here but I'm not taking the time to list them all. Do your DD and youll find them)

2015

March 2015 - SpectraScience Announces United Kingdom NHS Technology Alert

May 2015 - SpectraScience Technology Demonstrates Efficacy in Bladder Lesions

November 2015 - SpectraScience and JagWorldwide Enter Into Distribution Agreement

2016

January 2016 - SpectraScience to Display WavSTAT(R) Optical Biopsy System at Arab Health Conference

February 2016 - SpectraScience Acquires Assets of Oncoscope

...and here we are today. The point of this post is that, although it may 'feel' like' or 'appear like' nothing has happened for the past 4 years, we see in the above PRs that a LOT has happened! In fact, I left out the majority of PRs simply because theres too many to list. Think about it. What is one of the number one complaints investors have? At least for me its being invested in a company that never releases PR's, right?

Going to the numbers, since May 2012, Spectrascience has released 37 press releases! In 46 months, we got 37 press releases? And that's not including articles. So technically, 80% of the time we had new press releases to read.

In addition, listing out the press releases like they are above, it shows us the progress SCIE has made. Zacks 2012 said the problem with SCIE wasn't demand. Instead, it was lack of distribution! And ever since that report came out, SCIE got distribution, they went to countless shows and conferences, they pressed their product into trials (many of which are still ongoing), and finally.. after waiting the past 4 years, it feels like we're on the precipice of something major.
So, if youre one of the investors who, like myself, have wondered 'what the heck has SCIE been doing the past 4 years', read the PRs above. All the answers are right there. There are very strict guidelines set from the FDA that SCIE must meet. Remember, the forceps actually goes inside a human body, and someday it may help out one of us. SCIE has to get it right for safety's sake, and seeing they are still going strong, still in business, buying out other companies, doing trials, has PENTAX distribution, has JAG distribution, has FDA approval, has the CE mark... in my opinion, this year is going to be amazing.

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

HERVolution's HERV-K Antigens: A Cancer Breakthrough?

Updated Category News Views 120

Digging into HERVolution's Game-Changing Data Picture HERVolution in the spotlight, rolling out data that could shake up our approach to cancer immunotherapy. The big headline? HERV-K antigens might just be the whistle-blower we've been looking for to get the immune system off the bench and onto the field. How's that for a kick in the conventional wisdom of cancer...

Continue Reading
DAR Logs Massive 587,000 Service Hours Nationwide

Updated Category News Views 92

A Month of Patriotism and Service You've got to hand it to the Daughters of the American Revolution (DAR)—when they commit, they go all in. This year, they turned their usual Day of Service into a full-blown Month of Service, packing in over 587,000 hours of volunteering nationwide. From historic spots to food pantries, DAR members showed up, and honestly, it's the kind...

Continue Reading
Landis+Gyr's Q2 Gains and Future Strategies

Updated Category News Views 0

Landis+Gyr's Multi-Faceted Financial Leap In the unpredictable landscape of energy tech, Landis+Gyr has thrown down some noteworthy cards in their latest financial disclosures. We're talking a Q2 net revenue sitting pretty at $269.2 million, and it's no mistake they landed a record-smashing adjusted gross margin of 38.0%. All this while wrangling an order intake of $170.3...

Continue Reading
Casio's CMK?100: A Lightweight Marvel Blending Style and Utility

Updated Category News Views 77

A Timepiece That Redefines Everyday Elegance There's a new player in the vast realm of watches, and it's got tongues wagging: the Casio CMK?100. You don’t see that blend of style, comfort, and practicality grow on trees, my friend. Casio’s new offering, the CMK?100, wears its purpose on its titanium sleeve: lightweight and stylish, it’s a suave addition to any wrist...

Continue Reading
Yale's $10M Inflammation Initiative: Future Health Impact

Updated Category News Views 25

Yale’s Inflammation Research: Beyond the Basics Inflammation. It’s the kind of battle your own body wages from within, and Yale School of Medicine’s fresh $10 million grant from the Blavatnik Family Foundation means they’re marching deeper into the trenches. This is not another academic exercise; it’s about digging out the roots of diseases that are tough to pin...

Continue Reading
MPLX Adds Industry Veterans to Board Leadership

Updated Category News Views 38

A New Era for MPLX's Board Nothing shakes up the scene like announcing two heavyweights joining the board, and that's exactly what MPLX LP (NYSE: MPLX) just pulled off. Micheal G. Dunn and Bruce L. Niemeyer are coming onboard, effective November 1, 2026. With pedigrees that could make any industry insider nod in approval, these guys bring decades of experience to the...

Continue Reading
7-Eleven Rolls Out Korean Flavors in Bold Menu Shift

Updated Category News Views 155

7-Eleven's New Global Menu Twist October 2026 sees 7-Eleven, Inc. whip out an intriguing move, venturing east with its new Flavors of Korea menu. They're not just changing the game in convenience store aisles; they're dancing to the beat of global flavors—a shake-up fit for the world's largest convenience retailer. Think about bodega basics getting a spicy Korean...

Continue Reading
From Missouri to Market: A New Spin on Turkey Calls

Updated Category News Views 24

Innovating the Turkey Call Game You want innovation? Well, wrap your head around this: a Missouri inventor is flipping the script on turkey mouth calls. The goal? To ditch the wrinkles and make turkey hunting that much smoother. It might seem a bit niche, but when you've been around long enough, you know these 'niche' ideas can sometimes hatch golden eggs for investors....

Continue Reading
Bechtel's $1M Push for Wyoming's Skilled Trades Future

Updated Category News Views 204

Wyoming's Bid for Skilled Trades Revolution You’d think with all the talk about tech and white-collar jobs, we’ve forgotten the backbone that keeps the world ticking—skilled trades. Turns out, Bechtel hasn’t. The company just tossed a cool million at Wyoming's Laramie County Community College and Western Wyoming College. What’s that doing? It's jumpstarting...

Continue Reading
Trump Quotation Book Takes Unbiased Approach

Updated Category News Views 0

In the ever-evolving dance of political discourse, a new book strides onto the stage: Not My President, published by Palmetto Publishing. It’s a bold compilation of presidential utterances, capturing the words of Donald J. Trump in all their unvarnished glory. Stripped of analysis or comedic flair, each entry stands alone like a solitary figure at a cocktail party,...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Tomorrow's Healers: Dr. Zarkadas' Scholarship

Updated Category News Views 116

Empowering Future Medical Leaders The Dr. Konstantinos Zarkadas Scholarship for Future Doctors is now open for applications. This scholarship invites undergraduate students committed to the field of medicine to apply for a prestigious award. The scholarship, which amounts to a one-time award of $1,000, aims to assist a deserving student who exemplifies both academic...

Continue Reading
Pharma Two B and Hepion Pharmaceuticals Merge for Growth

Updated Category News Views 47

Pharma Two B and Hepion Pharmaceuticals Announce Merger KIRYAT ONO, ISRAEL and EDISON, N.J. — Pharma Two B Ltd., a leading late-stage pharmaceutical company focused on treating Parkinson’s Disease, has officially announced its merger with Hepion Pharmaceuticals, Inc. (Nasdaq: HEPA), which specializes in addressing chronic liver diseases. They have filed a registration...

Continue Reading
Applied Graphite Technologies Grants Stock Options to Team

Updated Category News Views 186

Applied Graphite Technologies' Recent Developments Applied Graphite Technologies Corporation (AGT) has made significant strides in its operations recently by granting 2,350,000 stock options to its consultants, directors, and officers. These options are set at an exercise price of $0.07, and they come with a five-year term, expiring on August 13, 2030. This move...

Continue Reading
Jefferson Solutions Group Sets Course for Strategic Growth

Updated Category News Views 7

Jefferson's Big Move: A Strategic Overhaul The winds of change are blowing over at Jefferson Solutions Group. This May, the company announced a heavy-duty strategic reorganization to better align with its astronomical ambitions for long-term growth. If you're the type that's got a soft spot for high-impact solutions and government gigs, pay attention, because this shift...

Continue Reading
Unbeatable Security Solutions for Your Home This Summer

Updated Category News Views 191

Unbeatable Security Solutions for Your Home This Summer As summer vacation approaches, ensuring the safety of your home becomes vital. Reolink, known for its innovative solutions in visual technology, has announced early Prime Day deals that will make securing your property both convenient and affordable. With these impressive offers, you can invest in top-rated security...

Continue Reading